Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Fátima Cardoso

1-50 of 195 results

View this query on the Wikidata Query Service
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

scientific article published in June 2007
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

scientific article
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

scientific article published on 2 March 2011
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer

scientific article
Clinical application of the 70-gene profile: the MINDACT trial

scientific article
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

scientific article
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article
Multidisciplinary meeting on male breast cancer: summary and research recommendations

scientific article
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

scientific article
1st International consensus guidelines for advanced breast cancer (ABC 1).

scientific article published on 16 March 2012
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

scientific article
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

scientific article published on 01 July 2002
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

scientific article published on October 2006
Multifactorial approach to predicting resistance to anthracyclines

scientific article published on 21 March 2011
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

scientific article
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy

scientific article published on 05 August 2009
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

article
Breast cancer in pregnancy: recommendations of an international consensus meeting

scientific article published on December 2010
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics.

scientific article
Comparison of prognostic gene expression signatures for breast cancer

scientific article
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 September 2011
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published in May 2010
BRCA in breast cancer: ESMO Clinical Practice Guidelines

scientific article published on 01 September 2011
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer

scientific article published on October 29, 2012
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

scientific article published in February 2002
The MINDACT trial: the first prospective clinical validation of a genomic tool

scientific article (publication date: December 2007)
First international consensus guidelines for breast cancer in young women (BCY1).

scientific article published on 24 April 2014
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).

scientific article
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

scientific article published on 25 November 2010
The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer--a systematic review

scientific article
Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

scientific article published on 01 June 2005
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase

scientific article published on 01 November 2011
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 September 2011
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

scientific article published on 15 July 2010
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

scientific article
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

scientific article
Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.

scientific article published on March 2007
Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

scientific article published on May 2001
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

scientific article
Breast cancer

scientific article published on 23 September 2019
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel

scientific article
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

scientific article published on 17 April 2013
Individualization of therapy using Mammaprint: from development to the MINDACT Trial

scientific article
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner

scientific article published on 5 December 2006
Second international consensus guidelines for breast cancer in young women (BCY2).

scientific article published on 06 February 2016
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

scientific article
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature.

scientific article
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

scientific article published on April 2014
Stemming resistance to HER-2 targeted therapy

scientific article published on 04 March 2009

Paulina is supported by:

About Paulina

Help